More on LYEL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (3.3 Score)

Upcoming Events

- Earnings (11/5/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lyell Immunopharma (NQ:LYEL)
Delayed: 22.46 +0.41 (1.86%)
Prev. Close $22.05  
Open$21.61 
52 Wk High$ 
52 Wk Low$ 
Day High$22.77 
Day Low$21.61 
P/E N/A  
EPS$ 
Volume42,370 

Friends, Peers and Foes (?): CRBU, GTBP, NRIX, SLS PRQR (more...)

Feb 23, 2026 08:00 AM Lyell Immunopharma Announces Participation in March Investor Conferences
Feb 12, 2026 08:48 PM Form 4 Lyell Immunopharma, Inc. For: Feb 11 Filed by: Seely Lynn
Feb 12, 2026 08:46 PM Form 4 Lyell Immunopharma, Inc. For: Feb 11 Filed by: Hill Stephen J.
Feb 12, 2026 08:45 PM Form 4 Lyell Immunopharma, Inc. For: Feb 11 Filed by: Lee Gary K.
Feb 12, 2026 08:45 PM Form 4 Lyell Immunopharma, Inc. For: Feb 11 Filed by: Lee Gary K.
Feb 12, 2026 07:30 AM Lyell begins dosing in phase 3 CAR T-cell trial for lymphoma
Feb 12, 2026 07:30 AM Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma
Feb 11, 2026 09:05 PM Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Hill Stephen J.
Feb 11, 2026 09:05 PM Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Hill Stephen J.
Feb 11, 2026 09:04 PM Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Lee Gary K.
View All Articles

Entities mentioned with LYEL

View All Entities